Back to Search Start Over

Heterogeneity of HSCs in a Mouse Model of NASH

Authors :
David A. Brenner
Ty D. Troutman
Rick Z. Li
Tatiana Kisseleva
Sara Brin Rosenthal
Martina P. Pasillas
Souradipta Ganguly
Xiao Liu
Eugenia Ricciardelli
Christopher K. Glass
Debanjan Dhar
Source :
Hepatology (Baltimore, Md.), vol 74, iss 2
Publication Year :
2021
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2021.

Abstract

Background and aims In clinical and experimental NASH, the origin of the scar-forming myofibroblast is the HSC. We used foz/foz mice on a Western diet to characterize in detail the phenotypic changes of HSCs in a NASH model. Approach and results We examined the single-cell expression profiles (scRNA sequencing) of HSCs purified from the normal livers of foz/foz mice on a chow diet, in NASH with fibrosis of foz/foz mice on a Western diet, and in livers during regression of NASH after switching back to a chow diet. Selected genes were analyzed using immunohistochemistry, quantitative real-time PCR, and short hairpin RNA knockdown in primary mouse HSCs. Our analysis of the normal liver identified two distinct clusters of quiescent HSCs that correspond to their acinar position of either pericentral vein or periportal vein. The NASH livers had four distinct HSC clusters, including one representing the classic fibrogenic myofibroblast. The three other HSC clusters consisted of a proliferating cluster, an intermediate activated cluster, and an immune and inflammatory cluster. The livers with NASH regression had one cluster of inactivated HSCs, which was similar to, but distinct from, the quiescent HSCs. Conclusions Analysis of single-cell RNA sequencing in combination with an interrogation of previous studies revealed an unanticipated heterogeneity of HSC phenotypes under normal and injured states.

Details

ISSN :
15273350 and 02709139
Volume :
74
Database :
OpenAIRE
Journal :
Hepatology
Accession number :
edsair.doi.dedup.....b6022cc9847791190e9c3129b60f889f
Full Text :
https://doi.org/10.1002/hep.31743